Two drugs from Pfizer and Eli Lilly & Co. that employ a new therapeutic approach showed promise in slowing the course of breast cancer, according to early-stage research released on Sunday.
Two drugs show promise in slowing breast cancer
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.